Key Huntington's Disease Treatment Market Players:
- Teva Pharmaceuticals Industries Ltd.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- UniQure
- Lupin
- Dr. Reddy’s Laboratories Ltd.
- Neurocrine Biosciences Ltd.
- Sun Pharmaceutical Industries Ltd.
- Pfizer, Inc.
- Lundbeck A/S
- Bausch Health Companies Inc.
- Hikma Pharmaceuticals PLC
- Ionis Pharmaceuticals
- Sage Therapeutics
- WaVe Life Sciences
- Azevan Pharmaceuticals
Huntington’s disease treatment market is projected to have a steady growth during the forecast period. Key market players are investing in research and development to reduce side effects of HD treatment drugs, and provide better palliative care for patients.
Some of the key market players are:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of huntington's disease treatment is assessed at USD 716.97 million.
Huntington's Disease Treatment Market size was valued at USD 658.31 million in 2025 and is likely to cross USD 1.69 billion by 2035, registering more than 9.9% CAGR during the forecast period i.e., between 2026-2035.
North America leads the Huntington’s Disease Treatment Market with a 34.8% share, fueled by strong R&D investments and growing need for HD treatment, enhancing growth prospects through 2026–2035.
Key players in the market include Teva Pharmaceuticals Industries Ltd., UniQure, Lupin, Wave Life Sciences, Azevan Pharmaceuticals, Dr. Reddy’s Laboratories Ltd., Neurocrine Biosciences Ltd..
